Hyaluronidase and trastuzumab and Lorcaserin Extended-Release Tablets
Determining the interaction of Hyaluronidase and trastuzumab and Lorcaserin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hyaluronidase / trastuzumab
Brand name: Herceptin Hylecta
Synonyms: Trastuzumab and Hyaluronidase
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hyaluronidase and trastuzumab-Lorcaserin Hydrochloride
- Hyaluronidase and trastuzumab-Lorcaserin Tablets
- Hyaluronidase and trastuzumab-Lorcet
- Hyaluronidase and trastuzumab-Lorcet Plus
- Hyaluronidase and trastuzumab-Lorcet Tablets
- Hyaluronidase and trastuzumab-Lorlatinib
- Lorcaserin Extended-Release Tablets-Hyaluronidase injection
- Lorcaserin Extended-Release Tablets-Hyaluronidase Injection (Human)
- Lorcaserin Extended-Release Tablets-Hyaluronidase Subcutaneous, Injection
- Lorcaserin Extended-Release Tablets-Hyate:C
- Lorcaserin Extended-Release Tablets-Hybrisil
- Lorcaserin Extended-Release Tablets-Hycamtin